Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer
Go back to Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer| ImmunoVaccine, Inc. (AMEX: IMMVF) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $0.65 | |||
| Open | $0.02 | 52 Week Low | $0.30 | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $0.00 | |||
| Volume | 546,020 | |||||
| (NASDAQ: IMV) | Delayed: 0.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.82 | 52 Week High | $ | |||
| Open | $29.79 | 52 Week Low | $ | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.82 | EPS | $ | |||
| Volume | 27,202 | |||||
